Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

DHMH : Medical Marijuana Commission

Natalie M. LaPrade Medical Marijuana Commission
Senate Bill 923 and House Bill 881, signed into law by Governor O’Malley on April 14, 2014, will significantly change the medical marijuana program being implemented by the Natalie M. LaPrade Medical Marijuana Commission.  The Commission is in the process of promulgating regulations to implement these changes.  All information regarding the program will be placed on this website as it becomes available.
Here is a link to the new law:

Press Releases:

Draft Regulations:

Draft Regulations for HB 1101 (2013)

These are draft regulations.  They have not been formally approved by either the Secretary of the Department of Health and Mental Hygiene or the Office of the Attorney General.

The Medical Marijuana Commission welcomes your comments, but please be advised that this is not the formal comment period.  The Commission hopes to review as many comments as possible prior to the March 25th meeting.  Please send your comments in writing to by March 14th.


Address inquiries to:

Upcoming meetings:
All meetings begin at 2:00 P.M.
May 27, 2014
June 24, 2014
July 22, 2014
August 26, 2014
September 23, 2014
October 21, 2014
November 25, 2014
December 23, 2014

Location:  Metro Executive Building
                4201 Patterson Avenue, Room 100
                Baltimore, MD  21215
Previous meetings:

April 22, 2014
Metro Executive Building
4201 Patterson Avenue, Room 100
Baltimore, MD  21215

Tuesday March 25th, 2pm
Metro Executive Building
4201 Patterson Avenue, 
Baltimore, MD  21215
Meeting Minutes

Thursday February 27th, 2pm
Maryland Health Care Commission
4160 Patterson Avenue, 
Baltimore, MD  21215
Meeting Minutes

Tuesday January 28, 2014 2PM - 4PM
Metro Executive Building
4201 Patterson Avenue, Room 100
Baltimore, MD  21215
Meeting Minutes

Thursday December 19th, 2013 2 PM

Department of Health and Mental Hygiene
Conference Room L1
Baltimore, Maryland  21201
Meeting Minutes
Tuesday November 19th, 2013 2PM
Department of Health and Mental Hygiene
Conference Room L3
Baltimore, Maryland  21201
Thursday, October 31 – 2:00 p.m.
State Office Center
301 W. Preston Street, 15th floor, Suite 1503, Conference Room #3
Baltimore, Maryland  21201
Meeting Agenda
Meeting Minutes
Tuesday, September 24, 2013 – 5:00 p.m.
Maryland Department of Health and Mental Hygiene
201 W. Preston Street, Conference Room L3 (on the lobby level)
Baltimore, Maryland  21201
Commission members:
Dario Broccolino, J.D.,was sworn in as State’s Attorney for Howard County in April 2008. Prior to joining the state’s attorney’s office Mr. Broccolino served as State’s Attorneys’ Coordinator for Maryland and the Executive Director of the Maryland State’s Attorney’s Association from 1988 to 1999. A veteran prosecutor, Mr. Broccolino served as an assistant state’s attorney in Baltimore City, serving under four state’s attorneys between 1977 and 1988. Toward the latter part of his service in Baltimore City, his expertise included the prosecution of economic crimes, arson, and narcotics. Mr. Broccolino received his Bachelor of Science degree from Loyola College in Maryland and his Juris Doctor from the University of Baltimore, School of Law.
William C. Charles, Pharm.D. is a clinical pharmacist specializing in discharge and readmission reduction at MedStar Franklin Square Medical Center in Baltimore.  Previously, Dr. Charles was a staff pharmacist at CVS Pharmacy in Oxon Hill, Maryland.  He received his Pharm.D. from University of Maryland, Baltimore and a Bachelor of Science degree in Biology from University of Maryland, College Park. 
Kevin W. Chen, Ph.D., MPH, is an associate professor in the Center for Integrative Medicine and Department of Psychiatry at the University of Maryland, School of Medicine.  Dr. Chen is an investigator conducting survey research on adolescent substance abuse, and conducting clinical studies investigating the clinical feasibility and efficacy of Chinese energy therapy for treating osteoarthritis and addiction. With intensive training in research methodology and statistics, Dr. Chen has had extensive experience in designing and implementing various research projects.  He is currently working on NIH- and foundation-funded research projects on the application of bio-energy therapy and self-help methods in the treatment of addiction, arthritis, cancer and other health problems.  Dr. Chen received a Ph.D. in Sociology from Pennsylvania State University, a Master of Arts in Social Psychology from Peking University, a Master of Public Health in Health Policy and Management, and a Bachelor of Arts in Philosophy.
Paul W. Davies, M.D., is the founding partner and president of KURE Pain Management, a large and growing pain management practice with eight locations in Maryland.  He is board certified in interventional pain management and completed his pain fellowship training at the Johns Hopkins School of Medicine.  He has over ten years experience in treating patients in pain and has treated thousands of patients during that period.  He earned his medical degree from the University of Manchester, England and has completed residencies at the University of Pittsburgh, Baylor College of Medicine in Houston, Albert Einstein Medical Center in Philadelphia and Western Pennsylvania Hospital. He was a post-doctoral fellow at Johns Hopkins School of Medicine.
Michael A. Horberg, M.D., MAS, FACP, FIDSA is Executive Director of Research and Community Benefit for the Mid-Atlantic Permanente Medical Group and the director of the Mid-Atlantic Permanente Research Institute. In that role, he has responsibility for all research efforts in Kaiser Permanente Mid-Atlantic, including clinical trials. He is also director of HIV/AIDS for Kaiser Permanente.  Dr. Horberg has extensive experience with medical marijuana for patients with chronic health conditions.  He is familiar with the research in the area of medical marijuana, including the therapeutic benefits, issues of dependence and the potential interactions with other medications.  He graduated from Boston University’s College of Liberal Arts and School of Medicine and completed his internal medicine residency at Michael Reese Hospital in Chicago (University of Chicago affiliate). He received his Master of Advanced Studies (Clinical Research) from University of California San Francisco.
Robert A. Lavin, M.D. is an attending physician on faculty at the University of Maryland, School of Medicine and the Kernan Hospital of Baltimore.  He is also Director of the Chronic Pain Management Program at the Baltimore Veterans Administration where he develops pain treatment policies and serves as chair of the Pain Treatment Committee.  Dr. Lavin is also a consultant at The Johns Hopkins Hospital.  Dr. Lavin received his M.D. from the George Washington University School of Medicine, a Master of Science degree in Genetics from the University of Washington and a Bachelor of Arts Degree in Biology from Brandeis University.
Shawn McNamara, Ed.D., M.S.N., R.N., is Assistant Dean of the School of Health Professions and Nursing Program Administrator for the Community College of Baltimore County.  Dr. McNamara is responsible for leadership and management of the largest undergraduate nursing program in Maryland which is multi-campus based.   Prior to his current position, Dr. McNamara was responsible for leadership and management of Harford Hospice, a home care, hospice and private duty organization.  Dr. McNamara received his Ed.D from Walden University in Baltimore and a Master of Science in Nursing from Towson University.
Deborah R. Miran was the president and founder of Miran Consulting, Inc.  There she advised both brand and generic drug makers on the FDA approval process and provided expert witness testimony in various cases involving product labeling and liability issues. Ms. Miran was the Senior Director of Regulatory Affairs for Alpharma where she was responsible for directing the submission activities for new and abbreviated new drug applications to the FDA.  Ms. Miran received a Bachelor of Science in Chemistry from Iowa State University. 
Colonel Harry Robshaw, III, is currently Chief of Police of the Cheverly Police Department.  Colonel Robshaw has 40 years of law enforcement experience, with an extensive background in narcotics enforcement, community policing and crime reduction through environmental design and in planning and incorporating crime deterrence strategies.  Colonel Robshaw retired at the rank of Captain from the Prince George’s County Policy Depoartment in 2001.  Colonel Robshaw received his Bachelor of Science degree from University of Maryland University College.
Nancy Rosen-Cohen, Ph.D., is an executive management professional with substantial experience in health care reform and corporate development.  Dr. Rosen-Cohen is the Executive director of the National Council on Alcoholism and Drug Dependence.  She was appointed to the Governor’s Medical Marijuana Model Program Workgroup in 2011.  This group was responsible for developing a model program for facilitating patient access to marijuana for medical purposes. Dr. Rosen-Cohen received a Doctor of Philosophy in Special Education from Indiana University and a Bachelor of Science in Special Education from Butler University.
Eric E. Sterling, Esq., has over 32 years of experience as a lawyer working on medical marijuana issues.  Since 1989 he has been the President of The Criminal Justice Policy Foundation, a private non-profit educational organization that helps educate the nation about criminal justice issues and failed global drug policy. Mr. Sterling was counsel to the U.S. House of Representatives Committee on the Judiciary from 1979 until 1989. On the staff of the Subcommittee on Crime, (Rep. William J. Hughes (D-NJ), Chairman), he was responsible for drug enforcement, gun control, money laundering, organized crime, pornography, terrorism, corrections, and military assistance to law enforcement, among many issues.   He received a Juris Doctor from Villanova University School of Law and a Bachelor of Arts from Haverford College.